Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IMNM - Immunome Inc.

IEX Last Trade
11.16
0.030   0.269%

Share volume: 3,187
Last Updated: Thu 26 Dec 2024 04:30:21 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 4.47%

PREVIOUS CLOSE
CHG
CHG%
$11.13
0.03
0.27%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0.46%
1 Month
-1.17%
3 Months
-22.72%
6 Months
-4.51%
1 Year
17.36%
2 Year
296.40%
Key data
Stock price
$11.16
P/E Ratio 
0.00
DAY RANGE
$10.86 - $11.13
EPS 
$0.00
52 WEEK RANGE
$9.36 - $30.96
52 WEEK CHANGE
$6.17
MARKET CAP 
911.625 M
YIELD 
N/A
SHARES OUTSTANDING 
60.054 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.34
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$982,518
AVERAGE 30 VOLUME 
$901,640
Company detail
CEO: Purnanand D. Sarma
Region: US
Website: immunome.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Immunome, Inc. discovers and develops antibody therapeutics for oncology and infectious disease. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Recent news